Literature DB >> 10522786

Effect of oral rotavirus/iscom vaccines on immune responses in gnotobiotic lambs.

L A van Pinxteren1, M G Bruce, I Campbell, A Wood, C J Clarke, A Bellman, B Morein, D R Snodgrass.   

Abstract

A comparison of the effect on the immune responses in gnotobiotic lambs was made between an iscom vaccine prepared from recombinant rotavirus VP6 protein, an inactivated rotavirus/iscom-matrix vaccine and a vaccine comprising inactivated rotavirus alone. All three vaccines induced immunological priming and some degree of protection was observed after a single oral dose. However, different immune responses were induced in response to a virulent infection. The group vaccinated with the rotavirus/iscom-matrix vaccine showed a Th2-like response characterised by rotavirus-specific antibodies and a down-regulation of IFNgamma in jejunal Peyer's patches. Both Th1-like and Th2-like immune responses were induced in the group receiving the VP6 vaccine as seen by significantly increased expressions of IFNgamma and IL-6 in the jejunal Peyer's patch together with an increased percentage of CD8+ T cells in the intestine and rotavirus-specific antibodies at mucosal surfaces. Iscom vaccines given orally have the ability to induce both Th1-like and Th2-like immune responses in a ruminant model.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10522786     DOI: 10.1016/s0165-2427(99)00087-2

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  6 in total

1.  Development of a Bacillus subtilis-based rotavirus vaccine.

Authors:  Sangun Lee; Boris R Belitsky; James P Brinker; Kathryn O Kerstein; David W Brown; John D Clements; Gerald T Keusch; Saul Tzipori; Abraham L Sonenshein; John E Herrmann
Journal:  Clin Vaccine Immunol       Date:  2010-09-01

2.  Inhibition of rotavirus infectivity by a neoglycolipid receptor mimetic.

Authors:  Daniel W Bergner; Theresa B Kuhlenschmidt; William P Hanafin; Lawrence D Firkins; Mark S Kuhlenschmidt
Journal:  Nutrients       Date:  2011-02-17       Impact factor: 5.717

Review 3.  Formulation technologies for oral vaccines.

Authors:  R R C New
Journal:  Clin Exp Immunol       Date:  2019-08-08       Impact factor: 4.330

Review 4.  Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.

Authors:  Emily M Plummer; Marianne Manchester
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010-09-24

Review 5.  Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model.

Authors:  Lijuan Yuan; Linda J Saif
Journal:  Vet Immunol Immunopathol       Date:  2002-09-10       Impact factor: 2.046

Review 6.  Rotavirus diarrhea in bovines and other domestic animals.

Authors:  K Dhama; R S Chauhan; M Mahendran; S V S Malik
Journal:  Vet Res Commun       Date:  2008-07-12       Impact factor: 2.459

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.